March 15, 2023
Researchers from Rowan and Durin Technologies announce highly accurate blood test for Alzheimer’s Disease
A team of researchers from Rowan-Virtua School of Osteopathic Medicine (Rowan-Virtua SOM) and Durin Technologies, Inc., have announced the results of a newly-designed blood test that can detect the presence of Alzheimer’s disease-related pathology up to 10 years before symptoms arise with a nearly 97 percent accuracy rate.
March 14, 2023
Autoantibody-Based Alzheimer's Test by Durin Technologies Moving Toward Potential Commercialization
Diagnostics firm Durin Technologies is moving toward commercialization of its blood-based test for the early detection of Alzheimer's disease.